publication venue for
- Microsatellite Instability in Near East Sebaceous Neoplasms: Toward Improved Prediction.. 30. 2022
- A Standardization Protocol for the In Situ Detection of SARS-CoV2 RNA and Proteins.. 30. 2022
- Expression Analysis of GD2 by Immunohistochemistry in Invasive Breast Carcinoma: Clinical and Pathologic Correlation.. 30. 2022
- A Subset of Intrahepatic Cholangiocarcinomas Express Albumin RNA as Detected by In Situ Hybridization.. 29. 2021
- Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues.. 29. 2021
- Does Simian Virus 40 (SV40) Have a Role in UK Malignant Pleural Mesothelioma? No Role is Identified in a Sensitive RNA In Situ Hybridization Study on Potentially Affected Birth Cohorts.. 28. 2020
- Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression.. 28. 2020
- Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors.. 28. 2020
- Immunohistochemical Detection of γ/δ T Lymphocytes in Formalin-fixed Paraffin-embedded Tissues.. 27. 2019
- Automated RNA In Situ Hybridization for 18 High Risk Human Papilloma Viruses in Squamous Cell Carcinoma of the Head and Neck: Comparison With p16 Immunohistochemistry.. 27. 2019
- RNA In Situ Hybridization for Epstein-Barr Virus and Cytomegalovirus: Comparison With In Situ Hybridization and Immunohistochemistry.. 27. 2019
- Utility of Stathmin-1 as a Novel Marker in Evaluating Anal Intraepithelial Neoplasia (AIN).. 27. 2019
- Comparison of β-Catenin and LEF1 Immunohistochemical Stains in Desmoid-type Fibromatosis and its Selected Mimickers, With Unexpected Finding of LEF1 Positivity in Scars.. 26. 2018
- Diagnostic Utility of PD-L1 Expression in Lung Adenocarcinoma: Immunohistochemistry and RNA In Situ Hybridization.. 26. 2018
- Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology.. 26. 2018
- Parafibromin, APC, and MIB-1 Are Useful Markers for Distinguishing Parathyroid Carcinomas From Adenomas.. 25. 2017
- Viral-induced Modulation of Multiple Checkpoint Proteins in Cancers.. 25. 2017
- Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy.. 25. 2017
- Modulation of PD-L1 and CD8 Activity in Idiopathic and Infectious Chronic Inflammatory Conditions.. 25. 2017
- GNAS Mutations in Fibrous Dysplasia: A Comparative Study of Standard Sequencing and Locked Nucleic Acid PCR Sequencing on Decalcified and Nondecalcified Formalin-fixed Paraffin-embedded Tissues.. 24. 2016
- Image-guided Coring for Large-scale Studies in Molecular Pathology.. 24. 2016
- Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ.. 24. 2016
- PIK3CA Mutations are Common in Many Tumor Types and are Often Associated With Other Driver Mutations.. 24. 2016
- Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.. 23. 2015
- Requisite analytic and diagnostic performance characteristics for the clinical detection of BRAF V600E in hairy cell leukemia: a comparison of 2 allele-specific PCR assays.. 23. 2015
- Immunohistochemical detection of the BRAF V600E mutant protein in colorectal neoplasms.. 23. 2015
- The role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer.. 23. 2015
- BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression.. 22. 2014
- Automated in situ hybridization for human papilloma virus.. 22. 2014
- Immunohistochemical Investigation of BRAF p.V600E mutations in thyroid carcinoma using 2 separate BRAF antibodies.. 22. 2014
- In search of the ideal immunopanel to distinguish metastatic mammary carcinoma from primary lung carcinoma: a tissue microarray study of 207 cases.. 22. 2014
- Melan A (A103) is not a marker of mesothelioma.. 21. 2013
- A new immunohistochemical ER/PR image analysis system: a multisite performance study.. 19. 2011
- Reading immunohistochemical slides on a computer monitor--a multisite performance study using 180 HER2-stained breast carcinomas.. 19. 2011
- The role of cytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphoma.. 18. 2010
- Potential role of tissue microarrays for the study of biomarker expression in benign breast disease and normal breast tissue.. 17. 2009
- p16 immunohistochemistry as an alternative marker to distinguish atypical lipomatous tumor from deep-seated lipoma.. 17. 2009
- NY-BR-1 is a differentiation antigen of the mammary gland.. 15. 2007
- Reduced CD1d expression in colonic epithelium in microscopic colitis.. 14. 2006
- Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer.. 13. 2005
- Assessment of T-cell clonality via T-cell receptor-gamma rearrangements in cutaneous T-cell-dominant infiltrates using polymerase chain reaction and single-stranded DNA conformational polymorphism assay.. 12. 2004
- Immunophenotypic and genotypic characterization of progression in follicular lymphomas.. 12. 2004
- Melan-A (A103) and inhibin expression in ovarian neoplasms.. 11. 2003
- p27 and cyclin E/D2 associations in testicular germ cell tumors: implications for tumorigenesis.. 11. 2003
- Expression of p27 and VHL in renal tumors.. 10. 2002
- Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas.. 9. 2001
- Immunohistochemistry cocktails are here to stay: Center of Medicare and Medicaid Services should revise its new reimbursement policy.. 20. 2012